CLDI: מכפיל מחיר לרווח לצמיחה Calidi Biotherapeutics

Calidi Biotherapeutics brings together leading cell biologists to create innovative stem cell platforms. The P/E to growth history on the GURU.Markets terminal linear chart reflects valuation dynamics, where the value 0.00 denotes the current metric. Calidi Biotherapeutics implements precise methods for delivering viruses to tumors, earning deep trust from the professional oncological community and the loyalty of long-term investors.

The PEG ratio compares the current P/E multiple with earnings growth rates, where a value below one signals a fundamental undervaluation of the asset relative to its expansion. By analyzing this indicator of undervaluation relative to growth, an investor can assess the market value of Calidi Biotherapeutics (CLDI) through the prism of the uniqueness of their platform for delivering oncolytic viruses into tumors via stem cells.